Walter H. Moos
InvestorManaging Director at Pandect Bioventures
About
Walter Moos is Managing Director of Pandect Bioventures with more than three decades of executive experience in pharmaceutical and biotechnology organizations. He has served as CEO of ShangPharma Innovation, president of SRI Biosciences (Stanford Research Institute), chairman and CEO of MitoKor (Migenix), and vice president at Chiron (Novartis) and Warner-Lambert/Parke-Davis (Pfizer). He holds an A.B. in chemistry from Harvard University and a Ph.D. in chemistry from the University of California, Berkeley, and has been an adjunct professor of pharmaceutical chemistry at UCSF since 1992.
Invests in
Biotech
Deals · 1
Circle PharmaBoard seat
via Pandect Bioventures · filed Jan 2025 · $117.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
